PE20120122A1 - Composicion farmaceutica que comprende un analgesico y vitaminas - Google Patents
Composicion farmaceutica que comprende un analgesico y vitaminasInfo
- Publication number
- PE20120122A1 PE20120122A1 PE2011001166A PE2011001166A PE20120122A1 PE 20120122 A1 PE20120122 A1 PE 20120122A1 PE 2011001166 A PE2011001166 A PE 2011001166A PE 2011001166 A PE2011001166 A PE 2011001166A PE 20120122 A1 PE20120122 A1 PE 20120122A1
- Authority
- PE
- Peru
- Prior art keywords
- vitamin
- solution
- pharmaceutical composition
- analgesic
- vitamins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: (A) UNA SAL DE KETOROLACO QUE COMPRENDE KETOROLACO TROMETAMINA EN CANTIDAD DE 2-30 mg QUE SE ENCUENTRA EN UNA UNIDAD DE SOLUCION ENTRE 0.25% -3.0%; (B) UN AGENTE PARA AJUSTAR EL PH DE LA SOLUCION ANTERIOR, AMORTIGUADORES, AGUA Y ALCOHOL ETILICO DONDE EL PH DE LA SOLUCION ES DE 7.5 A 9.5; (C) UNA UNIDAD DE SOLUCION DE VITAMINAS DEL COMPLEJO B QUE COMPRENDE: 15 A 250 mg O 0.25 A 15% DE VITAMINA B1 Y/O 15 A 250mg O 0.25-15% DE VITAMINA B6 Y/O 0.2-2% DE VITAMINA B12; (D) CONSERVADORES SELECCIONADOS DEL GRUPO DE PARABENOS O CUALQUIER OTRO PERMITIDO EN SOLUCIONES PARENTERALES. LA COMPOSICION COMPRENDE DOS UNIDADES DE SOLUCIONES PARENTERALES Y LA MEZCLA DE LAS MISMAS PRESENTA UN PH DE 3.5 A 5.5. DICHA COMPOSICION ES ESTABLE, SEGURA Y EFICAZ SIENDO UTIL EN EL TRATAMIENTO DEL DOLOR
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA/A/2006/004020A MXPA06004020A (es) | 2006-04-10 | Composicion farmaceutica que comprende un analgesico y vitaminas |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20120122A1 true PE20120122A1 (es) | 2012-03-09 |
Family
ID=38580737
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2011001166A PE20120122A1 (es) | 2006-04-10 | 2007-04-09 | Composicion farmaceutica que comprende un analgesico y vitaminas |
PE2007000424A PE20080363A1 (es) | 2006-04-10 | 2007-04-09 | Composicion farmaceutica que comprende ketorolaco y complejo b |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007000424A PE20080363A1 (es) | 2006-04-10 | 2007-04-09 | Composicion farmaceutica que comprende ketorolaco y complejo b |
Country Status (16)
Country | Link |
---|---|
US (1) | US20090227534A1 (es) |
EP (1) | EP2008655B1 (es) |
JP (1) | JP5244089B2 (es) |
AR (1) | AR060394A1 (es) |
BR (1) | BRPI0709967A2 (es) |
CA (1) | CA2649194C (es) |
CO (1) | CO6331430A2 (es) |
CR (1) | CR10360A (es) |
DO (1) | DOP2007000055A (es) |
EC (1) | ECSP088801A (es) |
ES (1) | ES2428342T3 (es) |
GT (1) | GT200800208A (es) |
HN (1) | HN2008001531A (es) |
PE (2) | PE20120122A1 (es) |
PL (1) | PL2008655T3 (es) |
WO (1) | WO2007116287A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008003230A (es) * | 2008-03-07 | 2009-09-07 | Senosiain S A De C V Lab | Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b. |
SI2616064T1 (sl) * | 2010-10-21 | 2019-12-31 | Rtu Pharmaceuticals Llc | Pripravki ketorolaka, pripravljeni za uporabo |
AU2013201465B2 (en) * | 2012-10-24 | 2016-03-03 | Rayner Surgical (Ireland) Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
TWI809304B (zh) | 2014-12-01 | 2023-07-21 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2823167A (en) * | 1955-03-29 | 1958-02-11 | Vitarine Co Inc | Stable vitamin b12-containing solution |
FR4492M (es) * | 1965-07-07 | 1966-10-10 | ||
US4564614A (en) * | 1984-10-11 | 1986-01-14 | Pfizer Inc. | Antiinflammatory methods |
US6051587A (en) | 1998-04-16 | 2000-04-18 | Medicure, Inc. | Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
US20030191187A1 (en) * | 2002-04-01 | 2003-10-09 | Lee Fang Yu | Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
MXPA02010828A (es) | 2002-11-04 | 2004-07-16 | Leopoldo Espinosa Abdala | Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. |
-
2007
- 2007-03-22 DO DO2007000055A patent/DOP2007000055A/es unknown
- 2007-04-09 PE PE2011001166A patent/PE20120122A1/es active IP Right Grant
- 2007-04-09 PE PE2007000424A patent/PE20080363A1/es not_active Application Discontinuation
- 2007-04-10 ES ES07734226T patent/ES2428342T3/es active Active
- 2007-04-10 PL PL07734226T patent/PL2008655T3/pl unknown
- 2007-04-10 EP EP07734226.9A patent/EP2008655B1/en not_active Not-in-force
- 2007-04-10 JP JP2009504843A patent/JP5244089B2/ja not_active Expired - Fee Related
- 2007-04-10 US US12/226,219 patent/US20090227534A1/en not_active Abandoned
- 2007-04-10 WO PCT/IB2007/000907 patent/WO2007116287A1/es active Application Filing
- 2007-04-10 CA CA2649194A patent/CA2649194C/en not_active Expired - Fee Related
- 2007-04-10 BR BRPI0709967-3A patent/BRPI0709967A2/pt not_active IP Right Cessation
- 2007-04-10 AR ARP070101491A patent/AR060394A1/es not_active Application Discontinuation
-
2008
- 2008-10-08 EC EC2008008801A patent/ECSP088801A/es unknown
- 2008-10-09 GT GT200800208A patent/GT200800208A/es unknown
- 2008-10-10 CR CR10360A patent/CR10360A/es not_active Application Discontinuation
- 2008-10-10 HN HN2008001531A patent/HN2008001531A/es unknown
- 2008-10-10 CO CO08108827A patent/CO6331430A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20080363A1 (es) | 2008-05-25 |
CO6331430A2 (es) | 2011-10-20 |
US20090227534A1 (en) | 2009-09-10 |
GT200800208A (es) | 2010-03-18 |
JP5244089B2 (ja) | 2013-07-24 |
WO2007116287A1 (es) | 2007-10-18 |
EP2008655B1 (en) | 2013-06-26 |
AR060394A1 (es) | 2008-06-11 |
ES2428342T3 (es) | 2013-11-07 |
DOP2007000055A (es) | 2007-10-31 |
EP2008655A1 (en) | 2008-12-31 |
CA2649194A1 (en) | 2007-10-18 |
CA2649194C (en) | 2014-12-30 |
BRPI0709967A2 (pt) | 2011-08-02 |
ECSP088801A (es) | 2009-01-30 |
JP2009533413A (ja) | 2009-09-17 |
HN2008001531A (es) | 2011-07-12 |
CR10360A (es) | 2009-02-20 |
PL2008655T3 (pl) | 2013-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20121072T1 (hr) | Postupci za davanje tetrahidrobiopterina, povezani pripravci i postupci mjerenja | |
US20060233892A1 (en) | Topiramate compositions for treatment of headache | |
EP2444072A3 (en) | Non-mucoadhesive film dosage forms | |
MA33044B1 (fr) | Composition pharmaceutique contenant des derives de glucopyranosyl diphenylmethane, sa forme posologique galenique, son procede de preparation et ses utilisations pour une regulation glycemique amelioree chez un patient | |
EA200602294A1 (ru) | Жевательная таблетка, таблетка для рассасывания и таблетка для глотания, содержащая кальцийсодержащее соединение в качестве активного вещества | |
PE20110711A1 (es) | Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmaceuticamente aceptables de la misma | |
AR057422A1 (es) | Uan composicion farmaceutica de liberacion modificada, proceso de preparacion de dicha composicion y metodo para emplear la misma | |
AR062167A1 (es) | Sistema de administracion gastrorretentivo | |
BRPI0513673B8 (pt) | método para produzir um medicamento para aumentar a eficácia e o transporte dos compostos biologicamente ativos enteralmente administrados, e composição farmacêutica | |
ES2720954T3 (es) | Formulaciones estabilizadas de estatina | |
EA201300314A8 (ru) | Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство | |
PE20120122A1 (es) | Composicion farmaceutica que comprende un analgesico y vitaminas | |
RU2015109566A (ru) | НОВЫЕ ЭКСТРАКТЫ ИЗ CYNARA SCOLYMUS, COFFEA spp. И OLEA EUROPAEA ДЛЯ ЛЕЧЕНИЯ МЕТАБОЛИЧЕСКОГО СИНДРОМА | |
BR0308229A (pt) | Medicamentos contendo ingredientes ativos que diminuem o nìvel de colesterol com liberação do ingrediente ativo de tempo tardio | |
AR026254A1 (es) | El uso de una preparacion de liberacion controlada para la preparacion de un medicamento para aumentar la dosis o la exposicion sistemica de un farmaco queinhibe la fosfodiesterasa 4 | |
BR0008057A (pt) | Forma cristalina de eplerenona apresentando velocidade de dissolução intensificada | |
WO2001081328A3 (en) | Thiazolidinedione analogues and their use for the treatment of diabetes | |
BRPI0410374A (pt) | composição farmacêutica que compreende valsartano | |
EA200800833A1 (ru) | Фармацевтическая липидная композиция в виде частиц | |
BR112015018144A8 (pt) | composição de emulsão água/óleo farmacêutica estável com gotículas de óleo manométricas, método para fazer a mesma e alta dose única de clopidogrel usada para tratar um paciente | |
Howick | Escaping from placebo prison | |
JP2019511996A5 (es) | ||
AR045070A1 (es) | Preparados farmaceuticos topicos de acido ascorbico con efecto post-antimicotico | |
KR890007728A (ko) | 진통제 제조방법 | |
AR044697A1 (es) | Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |